The DOI matches its Crossref record; 75 of the 76 references it cites were found in a registry or an index.
Gut microbiota regulate Alzheimer’s disease pathologies and cognitive disorders via PUFA-associated neuroinflammation
Open accessAbstract
Objective: This study is to investigate the role of gut dysbiosis in triggering inflammation in the brain and its contribution to Alzheimer’s disease (AD) pathogenesis. Design: We analysed the gut microbiota composition of 3×Tg mice in an age-dependent manner. We generated germ-free 3×Tg mice and recolonisation of germ-free 3×Tg mice with fecal samples from both patients with AD and age-matched healthy donors. Results: Microbial 16S rRNA sequencing revealed Bacteroides enrichment. We found a prominent reduction of cerebral amyloid-β plaques and neurofibrillary tangles pathology in germ-free 3×Tg mice as compared with specific-pathogen-free mice. And hippocampal RNAseq showed that inflammatory pathway and insulin/IGF-1 signalling in 3×Tg mice brain are aberrantly altered in the absence of gut microbiota. Poly-unsaturated fatty acid metabolites identified by metabolomic analysis, and their oxidative enzymes were selectively elevated, corresponding with microglia activation and inflammation. AD patients’ gut microbiome exacerbated AD pathologies in 3×Tg mice, associated with C/EBPβ/asparagine endopeptidase pathway activation and cognitive dysfunctions compared with healthy donors’ microbiota transplants. Conclusions: These findings support that a complex gut microbiome is required for behavioural defects, microglia activation and AD pathologies, the gut microbiome contributes to pathologies in an AD mouse model and that dysbiosis of the human microbiome might be a risk factor for AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Furthermore, SCFA supplementation has been found to trigger C/EBPβ/AEP signaling activation and induce cognitive impairment in GF 3xTg-AD mice.196”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [196]
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, an elevated level of secondary BA taurohyodeoxycholic acid was reported in the serum of GF 3xTg-AD mice receiving FMT from AD patients.196”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [196]
The cited source says what the claim attributes to it.
In the citing paper
“Chen et al. recently demonstrated that particular gut microbiota are associated with neuroinflammation resulting in the pathogenesis of Alzheimer's disease. 46”
From Three Tiers to biological escape velocity: The quest to outwit aging (2022) · cites this paper as [46]
In the citing paper
“Importantly, FMT from AD patients to GF 3xTg-AD mice restored the main AD pathologies and microglial activation.196”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [196]
In the citing paper
“Moreover, the majority of studies that reported the detrimental effects of SCFAs were conducted using GF mice,56,190,196,199 which are functionally and structurally abnormal across various physiological functions.313”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [196]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Chu, J., Giannopoulos, P. F., Ceballos‐Diaz, C., Golde, T. E., & Praticò, D. (2012) · Annals of Neurology · doi:10.1002/ana.23642 · Cited by 78
RetractedGiannopoulos, P. F., Chu, J., Joshi, Y. B., Sperow, M., Li, J.-G., Kirby, L. G., & Praticò, D. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.04.009 · Cited by 41
RetractedNeuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
Host microbiota constantly control maturation and function of microglia in the CNS
Erny, D., Hrabě de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4030 · Cited by 3,569
Normal gut microbiota modulates brain development and behavior
Heijtz, R. D., Wang, S., Anuar, F., Qian, Y., Björkholm, B., Samuelsson, A., Hibberd, M. L., Forssberg, H., & Pettersson, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010529108 · Cited by 3,228
Recognition of microorganisms and activation of the immune response
Medzhitov, R. (2007) · Nature · doi:10.1038/nature06246 · Cited by 2,862
The gut microbiota influences blood-brain barrier permeability in mice
Braniste, V., Al-Asmakh, M., Kowal, C., Anuar, F., Abbaspour, A., Tóth, M., Korecka, A., Bakocevic, N., Ng, L. G., Kundu, P., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009759 · Cited by 2,530
Gut microbiome alterations in Alzheimer’s disease
Vogt, N. M., Kerby, R. L., Dill-McFarland, K. A., Harding, S. J., Merluzzi, A. P., Johnson, S. C., Carlsson, C. M., Asthana, S., Zetterberg, H., Blennow, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13601-y · Cited by 2,137
Talbot, K., Wang, H.-Y., Kazi, H., Han, L.-Y., Bakshi, K. P., Stucky, A., Fuino, R. L., Kawaguchi, K. R., Samoyedny, A. J., Wilson, R. S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59903 · Cited by 1,871
Rivière, A., Selak, M., Lantin, D., Leroy, F., & Vuyst, L. D. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00979 · Cited by 1,810
Steen, E., Terry, B. M., J. Rivera, E., Cannon, J. L., Neely, T. R., Tavares, R., Xu, X. J., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7107 · Cited by 1,703
The interplay between the intestinal microbiota and the brain
Collins, S. M., Surette, M., & Bercik, P. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2876 · Cited by 1,611
Mi, H., Muruganujan, A., Huang, X., Ebert, D., Mills, C., Guo, X., & Thomas, P. D. (2019) · Nature Protocols · doi:10.1038/s41596-019-0128-8 · Cited by 1,512
Cattaneo, A., Cattane, N., Galluzzi, S., Provasi, S., Lopizzo, N., Festari, C., Ferrari, C., Guerra, U. P., Paghera, B., Muscio, C., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.08.019 · Cited by 1,382
Microglia development follows a stepwise program to regulate brain homeostasis
Matcovitch-Natan, O., Winter, D. R., Giladi, A., Vargas Aguilar, S., Spinrad, A., Sarrazin, S., Ben-Yehuda, H., David, E., Zelada González, F., Perrin, P., et al. (2016) · Science · doi:10.1126/science.aad8670 · Cited by 1,180
Plasma phospholipids identify antecedent memory impairment in older adults
Mapstone, M. E., Cheema, A. K., Fiandaca, M. S., Zhong, X., Mhyre, T. R., MacArthur, L. H., Hall, W. J., Fisher, S. G., Peterson, D. R., Haley, J. M., et al. (2014) · Nature Medicine · doi:10.1038/nm.3466 · Cited by 1,060
In-vivo measurement of activated microglia in dementia
Cagnin, A., Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., Jones, T., & Banati, R. B. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05625-2 · Cited by 1,054
Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta
Griciuc, A., Serrano-Pozo, A., Parrado, A. R., Lesinski, A. N., Asselin, C. N., Mullin, K., Hooli, B., Choi, S. H., Hyman, B. T., & Tanzi, R. E. (2013) · Neuron · doi:10.1016/j.neuron.2013.04.014 · Cited by 1,004
Innate immune memory in the brain shapes neurological disease hallmarks
Wendeln, A.-C., Degenhardt, K., Kaurani, L., Gertig, M., Ulas, T., Jain, G., Wagner, J., Häsler, L. M., Wild, K., Skodras, A., et al. (2018) · Nature · doi:10.1038/s41586-018-0023-4 · Cited by 956
Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota
Harach, T., Marungruang, N., Duthilleul, N., Cheatham, V., Mc Coy, K. D., Frisoni, G., Neher, J. J., Fåk, F., Jucker, M., Lasser, T., et al. (2017) · Scientific Reports · doi:10.1038/srep41802 · Cited by 901
Gut Microbiota is Altered in Patients with Alzheimer’s Disease
Zhuang, Z.-Q., Shen, L.-L., Li, W.-W., Fu, X., Zeng, F., Gui, L., Lü, Y., Cai, M., Zhu, C., Tan, Y.-L., et al. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-180176 · Cited by 885
Prostaglandin E2 synthesis and secretion: The role of PGE2 synthases
Park, J. Y., Pillinger, M. H., & Abramson, S. B. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.01.016 · Cited by 793
Liu, P., Wu, L., Peng, G., Han, Y., Tang, R., Ge, J., Zhang, L., Jia, L., Yue, S., Zhou, K., et al. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.05.008 · Cited by 669
Zhang, Z., Song, M., Liu, X., Kang, S. S., Kwon, I.-S., Duong, D. M., Seyfried, N. T., Hu, W. T., Liu, Z., Wang, J.-Z., et al. (2014) · Nature Medicine · doi:10.1038/nm.3700 · Cited by 494
Self-citationModulation of inflammation in brain: A matter of fat
Farooqui, A. A., Horrocks, L. A., & Farooqui, T. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04371.x · Cited by 460
A critical role for IGF-II in memory consolidation and enhancement
Chen, D. Y., Stern, S. A., García‐Osta, A., Saunier-Rebori, B., Pollonini, G., Bambah-Mukku, D., Blitzer, R. D., & Alberini, C. M. (2011) · Nature · doi:10.1038/nature09667 · Cited by 423
Haran, J. P., Bhattarai, S. K., Foley, S. E., Dutta, P., Ward, D. V., Bucci, V., & McCormick, B. A. (2019) · mBio · doi:10.1128/mbio.00632-19 · Cited by 412
Self-citationPhospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease
Sanchez-Mejia, R. O., Newman, J. W. I., Toh, S., Yu, G.-Q., Zhou, Y., Halabisky, B., Cissé, M., Scearce-Levie, K. A., Cheng, I. H.-J., Gan, L., et al. (2008) · Nature Neuroscience · doi:10.1038/nn.2213 · Cited by 362
Microglia Function in Central Nervous System Development and Plasticity
Schafer, D. P., & Stevens, B. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020545 · Cited by 353
Murakami, M., Nakashima, K., Kamei, D., Masuda, S., Ishikawa, Y., Ishii, T., Ohmiya, Y., Watanabe, K., & Kudo, I. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305108200 · Cited by 350
Nakayama, M., Uchimura, K., Zhu, R. L., Nagayama, T., Rose, M. E., Stetler, R. A., Isakson, P. C., Chen, J., & Graham, S. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10954 · Cited by 337
Altered Gut Microbiome Composition and Tryptic Activity of the 5xFAD Alzheimer’s Mouse Model
Brandscheid, C., Schuck, F., Reinhardt, S., Schäfer, K.-H., Pietrzik, C. U., Grimm, M., Hartmann, T., Schwiertz, A., & Endres, K. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-160926 · Cited by 318
Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation
Kang, Y.-J., Mbonye, U. R., DeLong, C. J., Wada, M., & Smith, W. L. (2007) · Progress in Lipid Research · doi:10.1016/j.plipres.2007.01.001 · Cited by 298
Sex-specific effects of microbiome perturbations on cerebral Aβ amyloidosis and microglia phenotypes
Dodiya, H. B., Kuntz, T., Shaik, S. M., Baufeld, C., Leibowitz, J., Zhang, X., Gottel, N., Zhang, X., Butovsky, O., Gilbert, J. A., et al. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20182386 · Cited by 288
Pan, X., Kaminga, A. C., Wen, S. W., Wu, X., Acheampong, K., & Liu, A. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00175 · Cited by 283
Zhang, Z., Song, M., Liu, X., Su Kang, S., Duong, D. M., Seyfried, N. T., Cao, X., Cheng, L., Sun, Y. E., Ping Yu, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms9762 · Cited by 277
Self-citationBäuerl, C., Collado, M. C., Diaz Cuevas, A., Viña, J., & Pérez Martínez, G. (2018) · Letters in Applied Microbiology · doi:10.1111/lam.12882 · Cited by 238
Behavioral assays with mouse models of Alzheimer's disease: Practical considerations and guidelines
Puzzo, D., Lee, L. S., Palmeri, A., Calabrese, G., & Arancio, O. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.011 · Cited by 226
Chen, C., Ahn, E. H., Kang, S. S., Liu, X., Alam, A., & Ye, K. (2020) · Science Advances · doi:10.1126/sciadv.aba0466 · Cited by 205
Self-citationCyclooxygenase-2 in synaptic signaling
Yang, H., & Chen, C. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784480144 · Cited by 195
Self-citationAltered arginine metabolism in Alzheimer's disease brains
Liu, P., Fleete, M. S., Yu, J., Collie, N. D., Curtis, M. A., Waldvogel, H. J., Faull, R. L. M., Abraham, W. C., & Zhang, H. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.013 · Cited by 187
Adesso, S., Magnus, T., Cuzzocrea, S., Campolo, M., Rissiek, B., Paciello, O., Autore, G., Pinto, A., & Marzocco, S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00370 · Cited by 184
Imaging Neuroinflammation in Alzheimer's Disease with Radiolabeled Arachidonic Acid and PET
Esposito, G., Giovacchini, G., Liow, J., Bhattacharjee, A. K., Greenstein, D. K., Schapiro, M. B., Hallett, M., Herscovitch, P., Eckelman, W. C., Carson, R. E., et al. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.049619 · Cited by 182
5‐Lipoxygenase gene disruption reduces amyloid‐β pathology in a mouse model of Alzheimer's disease
Firuzi, O., Zhuo, J., Chinnici, C. M., Wısnıewskı, T., & Praricò, D. (2007) · The FASEB Journal · doi:10.1096/fj.07-9131.com · Cited by 169
Ubiquitin Ligase COP1 Suppresses Neuroinflammation by Degrading c/EBPβ in Microglia
Ndoja, A., Reja, R., Lee, S.-H., Webster, J. D., Ngu, H., Rose, C. M., Kirkpatrick, D. S., Modrusan, Z. D., Chen, Y.-J. J., Dugger, D. L., et al. (2020) · Cell · doi:10.1016/j.cell.2020.07.011 · Cited by 161
Metabolic profiling of Alzheimer's disease brains
Inoue, K., Tsutsui, H., Akatsu, H., Hashizume, Y., Matsukawa, N., Yamamoto, T., & Toyo’oka, T. (2013) · Scientific Reports · doi:10.1038/srep02364 · Cited by 153
A metabolomic study of the CRND8 transgenic mouse model of Alzheimer's disease
Salek, R. M., Xia, J., Innes, A. E., Sweatman, B. C., Adalbert, R., Randle, S. J., McGowan, E. M., Emson, P. C., & Griffin, J. L. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.04.001 · Cited by 148
Phospholipase A2 and arachidonic acid in Alzheimer's disease
Sanchez-Mejia, R. O., & Mucke, L. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.05.013 · Cited by 148
Wang, Z.-H., Gong, K. Q., Liu, X., Zhang, Z., Sun, X., Wei, Z. Z., Yu, S. P., Manfredsson, F. P., Sandoval, I. M., Johnson, P. F., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04120-z · Cited by 140
Self-citationChen, C., Zhou, Y., Wang, H., Alam, A. M., Kang, S. S., Ahn, E. H., Liu, X., Jia, J., & Ye, K. (2021) · The EMBO Journal · doi:10.15252/embj.2020106320 · Cited by 138
Self-citationFOTI, D. P., Iuliano, R., CHIEFARI, E. D., & Brunetti, A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.8.2720-2732.2003 · Cited by 135
Age‐dependent impairment of glucose tolerance in the 3xTg‐AD mouse model of Alzheimer's disease
Vandal, M., White, P. J., Chevrier, G., Tremblay, C., St‐Amour, I., Planel, E., Marette, A., & Calon, F. (2015) · The FASEB Journal · doi:10.1096/fj.14-268482 · Cited by 107
Amtul, Z., Uhrig, M., Wang, L., Rozmahel, R. F., & Beyreuther, K. T. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.07.014 · Cited by 104
Straccia, M., Gresa‐Arribas, N., Dentesano, G., Ejarque‐Ortiz, A., Tusell, J. M., Serratosa, J., Solà, C., & Saura, J. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-156 · Cited by 95
Brain muscarinic receptors in senile dementia
Rinne, J. O., LAAKSO, K., Lönnberg, P., Mölsä, P. K., Paljärvi, L., Rinne, J. K., Säkö, E., & Rinne, U. K. (1985) · Brain Research · doi:10.1016/0006-8993(85)90411-1 · Cited by 89
Cyclooxygenase-1 null mice show reduced neuroinflammation in response to β-amyloid
Choi, S., & Bosetti, F. (2009) · Aging · doi:10.18632/aging.100021 · Cited by 87
Elevated microsomal prostaglandin‐E synthase‐1 in Alzheimer's disease
Chaudhry, U. A., Zhuang, H., Crain, B. J., & Doré, S. (2007) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2007.10.015 · Cited by 65
Cortés‐Canteli, M., Luna‐Medina, R., Sanz-SanCristóbal, M., Alvarez, A. M., Santos, Á., & Pérez‐Castillo, A. (2008) · Journal of Cell Science · doi:10.1242/jcs.025031 · Cited by 60
Yu, Y., Li, X., Blanchard, J., Li, Y., Iqbal, K., Liu, F., & Gong, C. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1294-z · Cited by 60
Serio, K. J., Reddy, K. V., & Bigby, T. D. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00296.2004 · Cited by 52
McCarthy, T. L., Ji, C., Chen, Y., & Kim, K. (2000) · Endocrinology · doi:10.1210/endo.141.1.7237 · Cited by 51
Healy, Z. R., Zhu, F., Stull, J. D., & Κωνσταντόπουλος, Κ. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00542.2007 · Cited by 48
Strohmeyer, R., Shelton, J. R., Lougheed, C., & Breitkopf, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086617 · Cited by 44
Ikeda‐Matsuo, Y., Hirayama, Y., Ota, A., Uematsu, S., Akira, S., & Sasaki, Y. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00595.x · Cited by 37
5-Lipoxygenase-activating Protein Gene Expression
Reddy, K. V., Serio, K. J., Hodulik, C. R., & Bigby, T. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211102200 · Cited by 37
A close look at pentose metabolism of gut bacteria
Basen, M., & Kurrer, S. E. (2020) · FEBS Journal · doi:10.1111/febs.15575 · Cited by 35
Insulin Regulates TRB3 and Other Stress-Responsive Gene Expression through Induction of C/EBPβ
Du, K., & Ding, J. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0284 · Cited by 32
Wang, H., Liu, X., Chen, S., & Ye, K. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815915115 · Cited by 32
Self-citationConteh, A. M., Reissaus, C. A., Hernández‐Pérez, M., Nakshatri, S., Anderson, R. M., Mirmira, R. G., Tersey, S. A., & Linnemann, A. K. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.007102 · Cited by 31
Kalsotra, A., Anakk, S., Brommer, C. L., Kikuta, Y., Morgan, E. T., & Strobel, H. W. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.02.027 · Cited by 28
Av, S., Trupp, A., Henkel, A. W., Bloch, E., Reulbach, U., Lewczuk, P., Riggert, J., Kornhuber, J., & Wiltfang, J. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.12.009 · Cited by 27
Straccia, M., Dentesano, G., Valente, T., Pulido-Salgado, M., Solà, C., & Saura, J. (2013) · Glia · doi:10.1002/glia.22542 · Cited by 19
Wu, Z., Liu, X., Cheng, L., & Ye, K. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03270-7 · Cited by 18
Self-citationChang, W., Rewari, A., & McCarthy, T. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405549200 · Cited by 17
Tang, Y., Xiong, K., Shen, M., Mu, Y., Li, K., & Liu, H. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2308-8 · Cited by 15
Research works printed but not linked: 1
- 10.1210/en.141.1.127 · DOI
Cited by
Sorted by citations
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
Self-citationDAMPs and DAMP-sensing receptors in inflammation and diseases
Ma, M., Jiang, W., & Zhou, R. (2024) · Immunity · doi:10.1016/j.immuni.2024.03.002 · Cited by 575
Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy
Shen, Y., Fan, N., Ma, S., Cheng, X., Yang, X., & Wang, G. (2025) · MedComm · doi:10.1002/mco2.70168 · Cited by 404
Current understanding of the Alzheimer’s disease-associated microbiome and therapeutic strategies
Seo, D.-O., & Holtzman, D. M. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01146-2 · Cited by 259
Metadata
- Authors
- Chen, C., Liao, J., Xia, Y., Liu, X., Jones, R., Haran, J., McCormick, B., Sampson, T. R., Alam, A., & Ye, K.
- Affiliations
- Emory University (US)
- University of Massachusetts Chan Medical School (US)
- University of Kentucky (US)
- Corresponding author
- Ye, Keqiang
- ORCID
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2022-01-11
- Volume
- 71
- Issue
- 11
- Pages
- 2233-2252
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- PMC
- PMC10720732
- OpenAlex
- W4205897663
- Cited by
- 491
- References
- 76
- Citations by year
- 2026: 116 · 2025: 141 · 2024: 136 · 2023: 79 · 2022: 19
- FWCI
- 31.50
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Gut (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Georgia Clinical and Translational Science Alliance (UL1TR002378)
- Alzheimer's Disease Research Center, Emory University (P30 AG066511)
- National Institute of Health (RO1, AG065177)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, gut microbiota, gut dysbiosis, neuroinflammation, polyunsaturated fatty acids, microglial activation, neurofibrillary tangles, germ-free mice, fecal microbiota transplantation, Bacteroides, insulin/IGF-1 signalling, cognitive impairment, hippocampus
- MeSH terms
- Gastrointestinal Microbiome, Neuroinflammatory Diseases, Alzheimer Disease, Animals, Cognition, Disease Models, Animal, Fatty Acids, Unsaturated, Humans, Inflammation, Insulin-Like Growth Factor I, RNA, Ribosomal, 16S, Mice, Plaque, Amyloid, Insulins, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
